The scientific research market is undergoing significant transformation, driven by advancements in artificial intelligence (AI) and disruptive technological innovations. The emergence of Claude Science by Anthropic, a groundbreaking AI tool for computational biology and drug development, exemplifies this transformation. Simultaneously, the lifting of US restrictions on certain AI models and the UN's concerns about global inequalities exacerbated by AI highlight the ethical and regulatory challenges facing the sector. Companies must navigate this complex landscape to maintain their competitiveness and relevance.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
